ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Neoadjuvant therapy for pancreatic cancer: Limitations and advances of response assessment

Xu, Jianwei*; Zhan, Hanxiang; Li, Feng; Hu, Sanyuan; Wang, Lei*山东大学
Oncology Reports2021-4DOI: 10.3892/or.2021.7977
8被引5阅读
引用收藏
分享

摘要

Neoadjuvant therapy (NAT) has been widely recommended for managing patients with borderline resectable pancreatic cancer and resectable tumors with high risk factors. Accurate evaluation of the response after NAT is crucial to decide surgery, which then improves the rate of R0 resection and avoids meaningless surgery. The response to NAT is currently evaluated by conventional radiological examination and changes of serum CA19-9 levels. However, these assessments cannot accurately reflect the response to NAT. This article describes the limitations and advances of NAT response evaluation in pancreatic cancer. The values of some traditional imaging techniques, including positron emission tomography, endoscopic ultrasound, and diffusion weighted magnetic resonance imaging, are discussed, as well as novel imaging modalities or biomarkers, such as radiomics, dual energy computed tomography and liquid biopsy.

学科与关键词

关键词
pancreatic cancerneoadjuvant therapyresponse evaluationimaging techniquesbiomarkers
相关
加载中…
  • An update on pancreatic cancer imaging, staging, and use of the PACT-UK radiology template pre- and post-neoadjuvant treatment
    Corallo, Carmelo; Al-Adhami, Abdullah S.*; Jamieson, Nigel; Valle, Juan; Radhakrishna, Ganesh; Moir, John; Albazaz, Raneem*British Journal of Radiology, 2024, 98(1165): 13-26.
  • Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis
    Pan, Long; Fang, Jing; Tong, Chenhao; Chen, Mingyu; Zhang, Bin; Juengpanich, Sarun; Wang, Yifan*; Cai, Xiujun*WORLD JOURNAL OF SURGICAL ONCOLOGY, BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 1, 2020-12-31.被引 4
  • Computer-Aided Detection for Pancreatic Cancer Diagnosis: Radiological Challenges and Future Directions
    Ramaekers, Mark*; Viviers, Christiaan G. A.; Janssen, Boris V.; Hellstrom, Terese A. E.; Ewals, Lotte; van der Wulp, Kasper; Nederend, Joost; Jacobs, Igor; Pluyter, Jon R.; Mavroeidis, Dimitrios; van der Sommen, Fons; Besselink, Marc G.; Luyer, Misha D. P.; EMTIC Oncology Collaborative GrpJournal of Clinical Medicine, 2023, 12(13): 4209.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Oncology Reports
发表日期
2021-04
卷期
第 45 卷, 第 4 期
页码
26
DOI
10.3892/or.2021.7977
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2018M632681]; Natural Science Foundation of China [81502051]; Shandong Provincial Natural Science Foundation, China [ZR2015HQ010, ZR2017MH032]

作者

  • X

    Xu, Jianwei (通讯) (第一作者)

    shandong univ

  • Z

    Zhan, Hanxiang

    shandong univ

查看全部 5 位作者收起作者
  • L

    Li, Feng

    shandong univ

  • H

    Hu, Sanyuan

    shandong univ

  • W

    Wang, Lei (通讯)

    shandong univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417